BRESCIANI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 8.861
AS - Asia 5.312
EU - Europa 4.121
SA - Sud America 686
AF - Africa 107
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.101
Nazione #
US - Stati Uniti d'America 8.490
SG - Singapore 1.609
VN - Vietnam 1.288
IT - Italia 1.103
CN - Cina 1.056
DE - Germania 694
HK - Hong Kong 576
RU - Federazione Russa 533
BR - Brasile 510
SE - Svezia 317
CA - Canada 312
IE - Irlanda 310
GB - Regno Unito 240
UA - Ucraina 209
IN - India 174
FR - Francia 152
FI - Finlandia 134
AT - Austria 102
ID - Indonesia 89
KR - Corea 85
BD - Bangladesh 66
TR - Turchia 60
AR - Argentina 59
PL - Polonia 56
NL - Olanda 48
IQ - Iraq 47
BE - Belgio 42
JP - Giappone 42
ES - Italia 41
DK - Danimarca 38
MX - Messico 38
ZA - Sudafrica 34
CO - Colombia 33
CH - Svizzera 32
EC - Ecuador 29
PH - Filippine 29
PK - Pakistan 27
SA - Arabia Saudita 24
UZ - Uzbekistan 18
KE - Kenya 17
MY - Malesia 17
VE - Venezuela 15
MA - Marocco 12
PY - Paraguay 12
TW - Taiwan 12
BG - Bulgaria 11
CZ - Repubblica Ceca 11
CL - Cile 10
IR - Iran 10
LT - Lituania 9
RO - Romania 9
EG - Egitto 8
LB - Libano 8
NP - Nepal 8
PS - Palestinian Territory 8
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
JO - Giordania 7
OM - Oman 7
TH - Thailandia 7
TN - Tunisia 7
UY - Uruguay 7
AU - Australia 6
KZ - Kazakistan 6
PE - Perù 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
CR - Costa Rica 5
EU - Europa 5
HN - Honduras 5
RS - Serbia 5
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
HU - Ungheria 4
PT - Portogallo 4
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
LY - Libia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
SN - Senegal 3
AO - Angola 2
GE - Georgia 2
GR - Grecia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MR - Mauritania 2
NG - Nigeria 2
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CV - Capo Verde 1
GA - Gabon 1
GT - Guatemala 1
Totale 19.091
Città #
Ann Arbor 1.573
Singapore 999
Ashburn 832
Hong Kong 562
Woodbridge 509
Wilmington 501
San Jose 497
Frankfurt am Main 479
Chandler 445
Fairfield 436
Ho Chi Minh City 395
Milan 330
Hanoi 305
Dublin 299
Houston 249
Seattle 225
Beijing 218
New York 193
Jacksonville 191
Toronto 185
Dearborn 172
Dallas 158
Los Angeles 157
Santa Clara 149
Cambridge 137
Chicago 129
Princeton 112
Hefei 109
Vienna 90
The Dalles 88
Jakarta 78
Seoul 76
Council Bluffs 74
Nanjing 73
Helsinki 70
Buffalo 63
Lauterbourg 58
Moscow 56
Shanghai 56
Da Nang 52
Rome 51
São Paulo 50
London 48
Altamura 45
Haiphong 45
Lawrence 42
Brussels 40
Munich 40
Guangzhou 39
Tokyo 36
Kent 33
Boardman 32
Lachine 32
Warsaw 31
Biên Hòa 29
Orem 29
Nuremberg 28
Pune 28
San Diego 28
Fremont 27
Baghdad 24
Denver 23
Elora 23
Monza 22
Poplar 22
Ha Long 21
Nanchang 21
Andover 20
Can Tho 20
Dong Ket 20
Brooklyn 19
Hải Dương 19
Rio de Janeiro 19
Stockholm 19
Atlanta 18
Changsha 18
Shenyang 18
Tashkent 18
Turku 18
Detroit 17
Hebei 17
San Francisco 17
Romola 16
Zurich 16
Amsterdam 15
Bari 15
Johannesburg 15
Montreal 15
Quận Bình Thạnh 15
Turin 15
Ankara 14
Carate Brianza 14
Phoenix 14
Thái Nguyên 14
Chennai 13
Jinan 13
Nairobi 13
Bắc Ninh 12
Kunming 12
Ninh Bình 12
Totale 12.799
Nome #
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 522
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 504
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 501
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 490
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 460
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 456
Growth hormone secretagogues and the regulation of calcium signaling in muscle 442
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 437
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 390
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 386
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 361
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 349
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 341
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 335
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 322
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 315
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 306
Feeding behavior during long-term hexarelin administration in young and old rats 303
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 302
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 302
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 301
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 300
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 294
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 293
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 291
Ghrelin in gastroenteric pathophysiology 288
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 285
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 285
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 284
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 282
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 281
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 280
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 276
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 275
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 274
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 273
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 271
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 269
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 268
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 262
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 261
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 257
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 253
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 252
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 247
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 247
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 246
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 239
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 238
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 237
Androgen therapy in neurodegenerative diseases 237
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 231
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 227
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 217
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 212
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 211
The role of androgens in women's health and wellbeing 210
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 203
La somatopausa: nuove prospettive terapeutiche 202
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 195
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 190
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 190
Uso di agonisti e antagonisti dei recettori per i growth hormone secretagogues per la prevenzione e il trattamento di convulsioni ed epilessia 168
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 167
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 140
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 139
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 132
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 129
Role of nutrition in degenerative disease 106
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model 74
Totale 19.513
Categoria #
all - tutte 57.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021296 0 0 0 0 0 0 0 0 0 0 137 159
2021/20221.033 116 109 121 83 56 75 46 46 30 86 96 169
2022/20231.866 186 484 216 182 142 268 31 118 115 19 56 49
2023/20241.156 38 58 67 77 134 281 218 52 74 23 21 113
2024/20252.808 153 234 213 189 234 166 220 133 168 376 237 485
2025/20267.394 1.294 689 578 780 809 361 1.008 313 616 608 338 0
Totale 19.513